Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
This study aimed to evaluate the efficacy of early antiviral treatment in preventing clinical deterioration in asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus 2 infected (COVID-19) patients in home isolation and to share our experiences with the ambulatory management...
Saved in:
Main Author: | Sitasuwan T. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/85377 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19
by: Ricardo Águas, et al.
Published: (2022) -
Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19
by: Washirasaksiri C.
Published: (2023) -
Assessement of outcomes following implementation of antiviral treatment guidelines for covid-19 during the first wave in thailand
by: Narumol Sawanpanyalert, et al.
Published: (2022) -
Early diagnosis by antigen test kit and early treatment by antiviral therapy: An ambulatory management strategy during COVID-19 crisis in Thailand
by: Sayabovorn N.
Published: (2023) -
META-ANALYSIS OF RNA-SEQUENCING DATA FROM COVID-19 PATIENT WITH SEVERE SYMPTOMS ACQUIRING DEXAMETHASONE TREATMENT
by: Rizky Irfansyah, Adam